Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walailuck Böhning

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Statistical Methods in Medical Research|April 1, 2008
Revisiting Youden's index as a useful measure of the misclassification error in meta-analysis of diagnostic studiesDankmar Böhning, Walailuck Böhning, Heinz Holling
BMC Medical Research Methodology|April 25, 2014
Meta-analysis and meta-modelling for diagnostic problemsSuphada Charoensawat, Walailuck Böhning, Dankmar Böhning, et al.
Statistical Methods in Medical Research|February 5, 2013
The covariate-adjusted frequency plotHeinz Holling, Walailuck Böhning, Dankmar Böhning, et al.
Psychometrika|February 8, 2022
Estimation of Effect Heterogeneity in Rare Events Meta-AnalysisHeinz Holling, Katrin Jansen, Walailuck Böhning, et al.
BMC Medical Research Methodology|November 30, 2016
Erratum to: Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
BMC Medical Research Methodology|October 30, 2016
Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
Statistical Methods in Medical Research|November 18, 2017
Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detectionDankmar Böhning, Wei Liu, Richard Ig Holt, et al.
Clinical Diabetes and Endocrinology|February 16, 2018
Why do endocrine profiles in elite athletes differ between sports?Peter H Sönksen, Richard I G Holt, Walailuck Böhning, et al.
Drug Testing and Analysis|February 19, 2016
Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletesRichard I G Holt, Nishan Guha, Walailuck Böhning, et al.
BMC Research Notes|September 7, 2018
A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|April 1, 2008
Revisiting Youden's index as a useful measure of the misclassification error in meta-analysis of diagnostic studiesDankmar Böhning, Walailuck Böhning, Heinz Holling
BMC Medical Research Methodology|April 25, 2014
Meta-analysis and meta-modelling for diagnostic problemsSuphada Charoensawat, Walailuck Böhning, Dankmar Böhning, et al.
Statistical Methods in Medical Research|February 5, 2013
The covariate-adjusted frequency plotHeinz Holling, Walailuck Böhning, Dankmar Böhning, et al.
Psychometrika|February 8, 2022
Estimation of Effect Heterogeneity in Rare Events Meta-AnalysisHeinz Holling, Katrin Jansen, Walailuck Böhning, et al.
BMC Medical Research Methodology|November 30, 2016
Erratum to: Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
BMC Medical Research Methodology|October 30, 2016
Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
Statistical Methods in Medical Research|November 18, 2017
Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detectionDankmar Böhning, Wei Liu, Richard Ig Holt, et al.
Clinical Diabetes and Endocrinology|February 16, 2018
Why do endocrine profiles in elite athletes differ between sports?Peter H Sönksen, Richard I G Holt, Walailuck Böhning, et al.
Drug Testing and Analysis|February 19, 2016
Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletesRichard I G Holt, Nishan Guha, Walailuck Böhning, et al.
BMC Research Notes|September 7, 2018
A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
Pageof 2